Dr. Rusdi Abd. Rashid is a graduate of University Malaya obtaining the degree MBBS in 1998. He continued with a Masters in Psychological Medicine in University of Malaya and completed his master degree in year 2006. He received  addiction training course  in Turning point , Melbourne in year 2007 and Open Medical Institute , Salzberg , Austria in year 2008. Subsequently, he undergo the fellowship program under  the WHO Collaborating Centre in Korea for Psychosocial Rehabilitation and Community Mental Health in the same  year. He is currently a senior lecturer in the University of Malaya and  the chief coordinator of the University Malaya Center for Addiction Sciences(UMCAS) and coordinator for substance abuse treatment services, University Malaya Medical Centre (UMMC). Dr Rusdi has involved with most of pilot addiction treatment program in Malaysia. He is a Clinical Co-investigator and Visiting psychiatrist for Pilot Methadone Program in Pengkalan Chepa Prison, Kota Bharu, Malaysia(2008-2009). He is also a clinical Co-investigator, Prison-Community Link Project on Harm Reduction (PICOL-HR or Project HARAPAN) 2009 – present.  He is a Committee members for National Methadone Maintenance Program, Malaysia(2006-present). He is a  Project Coordinator for Spiritual Enhanced Drug Addiction Rehabilitation (SEDAR) Program: Pilot Methadone Project in Ar-Rahman Mosque, Malaysia(2009-present). He is a Committee members and visiting psychiatrist for Pilot Methadone Program in Government Drug Rehabilitation Centre (PUSPEN PERSADA), Malaysia(2010-present) and  a Committee members and visiting Psychiatrist for Pilot Methadone Program in Aftercare Centre National Anti-Drug Agency (NADA)-2007-2009.

Dr Tan obtained her Doctor of Dental Surgery in 2009 from University of Sciences Malaysia. She served in the Ministry of Health since her graduation until 2019 while she received her membership with the Faculty of Dental Surgery (MFDS) of the Royal College of Surgeons Edinburgh and Master of Clinical Dentistry (Oral and Maxillofacial Surgery) with distinction from Universiti Malaya. Currently, she is a senior lecturer and Oral and Maxillofacial Surgeon at the Department of Oral Maxillofacial Clinical Sciences, Universiti Malaya. She is actively involved in the research in dental implantology, traumatology, dentoalveolar surgery and craniofacial deformity.

Dr. Md Jasim Uddin obtained his PhD in Pharmaceutical Sciences from the University of Greenwich, UK. Dr. Uddin has more than 12 years of experience in the areas of Pharmaceutics, Drug Delivery and Formulation Science. His research is mainly focused on the development of transdermal microneedle arrays (using 3D printing or moulding) for the transdermal delivery of active substances (e.g., small molecules or macromolecules). Due to his industrial experiences as a Formulation Scientist, at the Department of Drug Product Design, and the Worldwide Research & Development Unit at Pfizer UK, he also has a strong background in formulation, material sciences and characterization. He has established a strong collaborative network with colleagues in several UK-based academic institutions such as the Queen’s University of Belfast, and the Universities of Kent, Strathclyde and Greenwich. Furthermore, Dr. Uddin has received significant recognition through several poster and presentation awards (e.g., CRS Annual Meeting, PharmSci) over the last few years. As a part of his management & leadership experiences, he has contributed to the organization of several international conferences. He won the Young research scholar award (2022) from the World Academy of Sciences (TWAS), UNESCO, the Young Promising Researcher Award (2020) in the ICIBLS, Inventor I & Young Inventor Award (2020) in PHARM-IIDEx, Malaysia etc. He is a scientific advisor of the Drug Delivery & Therapeutics (An non-profit organization to promote science for research, innovation & technology transfer) and has actively played his role in the Special Issue, Recent Advances in Vaccine Delivery 2022, Pharmaceutics, MDPI (Guest Editor), Expert Opinion on Drug Delivery, Taylor & Francis Group, Signal Transduction and Targeted Therapy, Springer Nature Publishers etc.